141 related articles for article (PubMed ID: 30081812)
1. [Possible Genetic Predictors of Cardiovascular Complications After Coronary Artery Bypass Surgery].
Grinshtein YI; Kosinova AA; Grinshtein IY; Subbotina TN; Savchenko AA
Kardiologiia; 2018 Jul; 58(7):77-84. PubMed ID: 30081812
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting.
Grinshtein YI; Kosinova AA; Grinshtein IY; Subbotina TN; Savchenko AA
Genet Test Mol Biomarkers; 2018 Apr; 22(4):259-265. PubMed ID: 29461866
[TBL] [Abstract][Full Text] [Related]
3. Myocardial infarction before and after the age of 45: Possible role of platelet receptor polymorphisms.
Pina-Cabral LB; Carvalhais V; Mesquita B; Escórcio C; Silva PF; Pinto P; Napoleão P; Pinheiro T; Monteiro MC; Almeida-Dias A; Criado B
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):727-735. PubMed ID: 30143348
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet reactivity during combined antiplatelet therapy in patients with stable coronary artery disease in relation to diabetes type 2 and the GPIIB/IIIA receptor gene polymorphism.
Jastrzebska M; Lisman D; Szelepajlo A; Oledzki S; Chelstowski K; Clark JS; Siennicka A
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356179
[TBL] [Abstract][Full Text] [Related]
5. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of response to clopidogrel and cardiovascular events.
Simon T; Verstuyft C; Mary-Krause M; Quteineh L; Drouet E; Méneveau N; Steg PG; Ferrières J; Danchin N; Becquemont L;
N Engl J Med; 2009 Jan; 360(4):363-75. PubMed ID: 19106083
[TBL] [Abstract][Full Text] [Related]
7. [Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy].
Muslimova EF; Afanasiev SA; Rebrova TY; Sergienko TN; Repin AN
Ter Arkh; 2017; 89(5):74-78. PubMed ID: 28631703
[TBL] [Abstract][Full Text] [Related]
8. Effect of platelet receptor gene polymorphisms on outcomes in ST-elevation myocardial infarction patients after percutaneous coronary intervention.
Zhang JH; Wang J; Tang XF; Yao Y; Zhang Y; Ma YL; Xu B; Gao RL; Song L; Gao Z; Chen J; Wu Y; Yang YJ; Meng XM; Yuan JQ
Platelets; 2016; 27(1):75-9. PubMed ID: 25901734
[TBL] [Abstract][Full Text] [Related]
9. Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.
Giusti B; Gori AM; Marcucci R; Sestini I; Saracini C; Paniccia R; Poli S; Giglioli C; Valente S; Prisco D; Gensini GF; Abbate R
Atherosclerosis; 2008 Jan; 196(1):341-348. PubMed ID: 17157856
[TBL] [Abstract][Full Text] [Related]
10. [Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel].
Cano P; Consuegra-Sánchez L; Conesa P; Torres-Moreno D; Jaulent L; Dau D; Picó F; Villegas M
Med Clin (Barc); 2014 Jul; 143(1):6-12. PubMed ID: 23850044
[TBL] [Abstract][Full Text] [Related]
11. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J
EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use.
Voora D; Horton J; Shah SH; Shaw LK; Newby LK
Am Heart J; 2011 Jul; 162(1):166-72.e1. PubMed ID: 21742104
[TBL] [Abstract][Full Text] [Related]
13. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
14. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
15. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
[TBL] [Abstract][Full Text] [Related]
16. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
[TBL] [Abstract][Full Text] [Related]
17. Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
Zhang D; Zhang X; Liu D; Liu T; Cai W; Yan C; Han Y
Cardiovasc Diabetol; 2016 Mar; 15():50. PubMed ID: 27005817
[TBL] [Abstract][Full Text] [Related]
18. Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report.
Golanski J; Golanski R; Chizynski K; Iwaszkiewicz A; Rozalski M; Wieclawska B; Boncler M; Watala C
Platelets; 2001 Jun; 12(4):241-7. PubMed ID: 11454259
[TBL] [Abstract][Full Text] [Related]
19. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance.
Siasos G; Oikonomou E; Vavuranakis M; Kokkou E; Mourouzis K; Tsalamandris S; Zaromitidou M; Kioufis S; Tsigkou V; Deftereos S; Stefanadis C; Tousoulis D
Cardiology; 2017; 137(2):104-113. PubMed ID: 28329746
[TBL] [Abstract][Full Text] [Related]
20. [Association of the integrin gene polymorphisms with ischemic stroke and plasma lipid levels].
Wei YS; Lan Y; Liu YG; Meng LQ; Xu QQ; Xie HY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):211-5. PubMed ID: 19350519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
